← brief for 2026-08-31 · Slowing decline

Adynamic Bone Disease in Chronic Kidney Disease: From PTH Suppression-Driven Remodeling Phenotype to Osteoanabolic Therapy.

Article No results yet Peer reviewed

Key takeaways

This review covers adynamic bone disease, where bone stops rebuilding itself in advanced kidney disease. The authors argue the main cause is treatment that pushes parathyroid hormone (PTH, a hormone that controls calcium) too low. They also point to kidney waste products and vitamin D signaling problems as contributors, and discuss bone-building drugs as a possible answer. This is a summary of past work, so there are no new results here.

Who did this work

Lu KC · Hou YC · Wu CC · Fang TC · Hung KC · Lu CL

Source

Article · PubMed, CKD progression and prevention · 2026 Aug 31
https://pubmed.ncbi.nlm.nih.gov/42671953/